SECsense Logo

Amgen Inc. Financial Report: 8-K Filing Insights on Stock & Notes

$AMGN
Form 8-K
Filed on: 2025-08-05
Source
Amgen Inc. Financial Report: 8-K Filing Insights on Stock & Notes

Based on the provided XML section of the financial report, here are the key pieces of information extracted:

  1. Company Information:
  • Name: Amgen Inc.
  • Address: One Amgen Center Drive, Thousand Oaks, CA 91320-1799
  • Phone Number: 805-447-1000
  • CIK: 0000318154
  • Exchange Listings: NASDAQ
  1. Financial Instruments:
  • Common Stock:
    • Par Value: $0.0001
    • Ticker Symbol: AMGN
  • Senior Notes:
    • Type: 2.000% Senior Notes due 2026
    • Ticker Symbol: AMGN26
  1. SEC Filing Information:
  • Filing Type: 8-K
  • Filing Date: August 5, 2025
  • Document Context:
    • The report references multiple contexts, including common stock and senior notes, indicating that it covers both equity and debt instruments.
  1. Reporting Period:
  • Start Date: August 5, 2025
  • End Date: August 5, 2025
  1. Stock and Notes Classification:
  • The common stock is classified under US GAAP as "CommonStockMember".
  • The senior notes are classified as "A2.00SeniorNotesDue2026Member".

Insights:

  • The report indicates that Amgen is actively managing both its equity (common stock) and debt (senior notes), which is typical for a large corporation looking to finance operations or growth.
  • The issuance of senior notes at a 2.000% interest rate suggests a low borrowing cost, which may be beneficial for capital projects or refinancing existing debt.
  • The timing of the 8-K filing may indicate a significant event or update regarding the company’s financial condition or corporate actions taking place on the same day as the report.

Overall, this segment of the financial report provides a snapshot of Amgen Inc.'s financial instruments and recent corporate filing, which is critical for investors and analysts monitoring the company's financial health and strategic direction.